B-Box and SPRY Domain Containing (BSPRY) (C-Term) Peptide
BSPRY
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BSPRY products
- BSPRY (B-Box and SPRY Domain Containing (BSPRY))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- TEDIRIDERT VSPFLQLSDD RKTLTFSTKK SKACADGPER FDHWPNALAA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BSPRY Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BSPRY (B-Box and SPRY Domain Containing (BSPRY))
- Synonyms
- B-box and SPRY domain containing Peptide, BSPRY Peptide, Bspry Peptide
- Background
-
BSPRY may regulate epithelial calcium transport by inhibiting TRPV5 activity.
Alias Symbols: FLJ20150
Protein Interaction Partner: SLC34A1,YWHAZ,ZYX
Protein Size: 301 - Molecular Weight
- 33 kDa
- Gene ID
- 54836
- NCBI Accession
- NM_017688, NP_060158
-
You are here:
